Psoriasis Vulgaris
Conditions
Interventions
experimental group:Mongolian mind-body interactive psychotherapy
control group:Psoriasis health education
Sponsors
Inner Mongolia International Mongolia Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as psoriasis vulgaris (based on the Chinese guidelines for the diagnosis and treatment of psoriasis vulgaris), with unlimited severity of psoriasis vulgaris; 2. The subjects were 0-60 years old, with no gender limit, who were willing to use contraception during the clinical study; 3. Patients with disease course less than 5 years; 4. Psoriasis Life Stress Scale (plsi) is less than 20 points (patients over 18 years old), or the Psoriasis Life Stress Scale (plsi) is greater than 20 points (patients over 18 years old), but the course of disease is less than 2 years. 5. Patients who voluntarily participate in this clinical study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with other skin diseases (such as eczema) that may affect the results of the study; 2. Patients with severe infection; 3. Patients who have taken antibiotics within 1 week; 4. The patients who had been treated with UVB within 2 weeks and those who had been treated with PUVA within 4 weeks; 5. Patients who have received any type of biological inhibition therapy within 2 months; 6. Patients who have used cortisol drugs, psoriasis drugs and anti-inflammatory drugs within one month; 7. Patients who have received Mongolian medicine, traditional Chinese medicine or other traditional medicine treatment within 2 weeks, and those who have participated in psychosomatic interaction therapy of Mongolian medicine need to stop for more than 2 weeks before they can participate in this study. 8. Patients with malignant tumor; 9. Patients with severe heart disease and abnormal liver and kidney function; 10. Pregnant women or pregnant patients; 11. Patients who have recently participated in or are participating in other clinical studies; 12. The patient's medical history or mental illness will affect the patient's compliance with the protocol. History of alcohol or drug abuse that affects compliance with the study protocol; 13. As well as any other circumstances that affect the results of the study as judged by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PASI;two years recurrence rate; | — |
Countries
China
Contacts
Public ContactNagongbilige He
Inner Mongolia International Mongolian Hospital
Outcome results
None listed